Teva Pharmaceutical Industries Limited (TEVA)
USD 21.2
(1.53%)
USD 21.2
(1.53%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 43.47 Billion USD | -1.2% |
| 2022 | 44 Billion USD | -7.68% |
| 2021 | 47.66 Billion USD | -5.87% |
| 2020 | 50.64 Billion USD | -11.88% |
| 2019 | 57.47 Billion USD | -5.29% |
| 2018 | 60.68 Billion USD | -14.07% |
| 2017 | 70.61 Billion USD | -23.98% |
| 2016 | 92.89 Billion USD | 71.2% |
| 2015 | 54.25 Billion USD | 16.88% |
| 2014 | 46.42 Billion USD | -2.29% |
| 2013 | 47.5 Billion USD | -6.13% |
| 2012 | 50.6 Billion USD | 0.93% |
| 2011 | 50.14 Billion USD | 28.4% |
| 2010 | 39.05 Billion USD | 15.5% |
| 2009 | 33.81 Billion USD | 2.75% |
| 2008 | 32.9 Billion USD | 40.54% |
| 2007 | 23.41 Billion USD | 14.37% |
| 2006 | 20.47 Billion USD | 97.08% |
| 2005 | 10.38 Billion USD | 7.84% |
| 2004 | 9.63 Billion USD | 62.82% |
| 2003 | 5.91 Billion USD | 27.86% |
| 2002 | 4.62 Billion USD | 33.72% |
| 2001 | 3.46 Billion USD | 21.17% |
| 2000 | 2.85 Billion USD | 66.6% |
| 1999 | 1.71 Billion USD | 19.36% |
| 1998 | 1.43 Billion USD | 20.83% |
| 1997 | 1.18 Billion USD | -4.27% |
| 1996 | 1.24 Billion USD | 42.48% |
| 1995 | 871.3 Million USD | 28.89% |
| 1994 | 676 Million USD | 20.09% |
| 1993 | 562.9 Million USD | 26.49% |
| 1992 | 445 Million USD | 18.13% |
| 1991 | 376.7 Million USD | 9.57% |
| 1990 | 343.8 Million USD | 19.92% |
| 1989 | 286.7 Million USD | 15.56% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 42.77 Billion USD | -1.62% |
| 2024 Q2 | 41.33 Billion USD | -3.35% |
| 2023 Q1 | 43.45 Billion USD | -1.25% |
| 2023 Q3 | 42.08 Billion USD | -2.34% |
| 2023 Q2 | 43.09 Billion USD | -0.83% |
| 2023 Q4 | 43.47 Billion USD | 3.3% |
| 2023 FY | 43.47 Billion USD | -1.2% |
| 2022 Q4 | 44 Billion USD | -0.56% |
| 2022 Q1 | 47.05 Billion USD | -1.27% |
| 2022 Q2 | 45.93 Billion USD | -2.39% |
| 2022 FY | 44 Billion USD | -7.68% |
| 2022 Q3 | 44.25 Billion USD | -3.66% |
| 2021 Q2 | 49.19 Billion USD | 0.39% |
| 2021 Q1 | 49 Billion USD | -3.23% |
| 2021 Q4 | 47.66 Billion USD | -0.39% |
| 2021 Q3 | 47.85 Billion USD | -2.73% |
| 2021 FY | 47.66 Billion USD | -5.87% |
| 2020 Q2 | 54.99 Billion USD | -0.61% |
| 2020 Q3 | 49.73 Billion USD | -9.55% |
| 2020 Q1 | 55.33 Billion USD | -3.72% |
| 2020 Q4 | 50.64 Billion USD | 1.82% |
| 2020 FY | 50.64 Billion USD | -11.88% |
| 2019 Q4 | 57.47 Billion USD | 0.39% |
| 2019 Q2 | 59.42 Billion USD | -0.72% |
| 2019 FY | 57.47 Billion USD | -5.29% |
| 2019 Q1 | 59.85 Billion USD | -1.37% |
| 2019 Q3 | 57.24 Billion USD | -3.67% |
| 2018 Q2 | 67.03 Billion USD | -3.11% |
| 2018 Q1 | 69.18 Billion USD | -2.03% |
| 2018 FY | 60.68 Billion USD | -14.07% |
| 2018 Q4 | 60.68 Billion USD | -6.73% |
| 2018 Q3 | 65.06 Billion USD | -2.94% |
| 2017 Q1 | 91.27 Billion USD | -1.74% |
| 2017 Q3 | 86.08 Billion USD | -0.32% |
| 2017 FY | 70.61 Billion USD | -23.98% |
| 2017 Q2 | 86.35 Billion USD | -5.39% |
| 2017 Q4 | 70.61 Billion USD | -17.97% |
| 2016 Q1 | 55.12 Billion USD | 1.6% |
| 2016 FY | 92.89 Billion USD | 71.2% |
| 2016 Q3 | 98.74 Billion USD | 70.49% |
| 2016 Q4 | 92.89 Billion USD | -5.93% |
| 2016 Q2 | 57.92 Billion USD | 5.07% |
| 2015 Q3 | 48.62 Billion USD | -3.47% |
| 2015 FY | 54.25 Billion USD | 16.88% |
| 2015 Q2 | 50.37 Billion USD | 7.28% |
| 2015 Q1 | 46.95 Billion USD | 1.14% |
| 2015 Q4 | 54.25 Billion USD | 11.58% |
| 2014 Q2 | 46.73 Billion USD | -0.34% |
| 2014 Q1 | 46.89 Billion USD | -1.3% |
| 2014 Q4 | 46.42 Billion USD | -0.4% |
| 2014 FY | 46.42 Billion USD | -2.29% |
| 2014 Q3 | 46.6 Billion USD | -0.27% |
| 2013 Q1 | 48.06 Billion USD | -5.02% |
| 2013 Q2 | 47.5 Billion USD | -1.18% |
| 2013 FY | 47.5 Billion USD | -6.13% |
| 2013 Q4 | 47.5 Billion USD | -0.71% |
| 2013 Q3 | 47.85 Billion USD | 0.73% |
| 2012 FY | 50.6 Billion USD | 0.93% |
| 2012 Q1 | 50.47 Billion USD | 0.65% |
| 2012 Q4 | 50.6 Billion USD | 2.08% |
| 2012 Q2 | 48.88 Billion USD | -3.15% |
| 2012 Q3 | 49.58 Billion USD | 1.43% |
| 2011 Q2 | 40.15 Billion USD | 2.3% |
| 2011 Q1 | 39.25 Billion USD | 2.89% |
| 2011 Q4 | 50.14 Billion USD | 21.47% |
| 2011 Q3 | 41.27 Billion USD | 2.79% |
| 2011 FY | 50.14 Billion USD | 28.4% |
| 2010 Q1 | 34.05 Billion USD | 0.71% |
| 2010 Q4 | 38.15 Billion USD | -2.26% |
| 2010 Q3 | 39.03 Billion USD | 10.95% |
| 2010 Q2 | 35.18 Billion USD | 3.33% |
| 2010 FY | 39.05 Billion USD | 15.5% |
| 2009 FY | 33.81 Billion USD | 2.75% |
| 2009 Q2 | 32.25 Billion USD | 0.02% |
| 2009 Q3 | 33.29 Billion USD | 3.24% |
| 2009 Q4 | 33.81 Billion USD | 1.55% |
| 2009 Q1 | 32.24 Billion USD | -2.01% |
| 2008 Q2 | 25.02 Billion USD | 1.58% |
| 2008 Q1 | 24.63 Billion USD | 5.21% |
| 2008 FY | 32.9 Billion USD | 40.54% |
| 2008 Q3 | 24.96 Billion USD | -0.21% |
| 2008 Q4 | 32.9 Billion USD | 31.79% |
| 2007 Q1 | 21.02 Billion USD | 2.72% |
| 2007 Q2 | 21.74 Billion USD | 3.42% |
| 2007 Q3 | 22.49 Billion USD | 3.44% |
| 2007 Q4 | 23.41 Billion USD | 4.08% |
| 2007 FY | 23.41 Billion USD | 14.37% |
| 2006 FY | 20.47 Billion USD | 97.08% |
| 2006 Q3 | 20 Billion USD | 3.29% |
| 2006 Q4 | 20.47 Billion USD | 2.33% |
| 2006 Q1 | 18.36 Billion USD | 76.78% |
| 2006 Q2 | 19.36 Billion USD | 5.48% |
| 2005 Q2 | 9.43 Billion USD | -0.84% |
| 2005 Q1 | 9.51 Billion USD | -1.21% |
| 2005 FY | 10.38 Billion USD | 7.84% |
| 2005 Q4 | 10.38 Billion USD | 7.45% |
| 2005 Q3 | 9.66 Billion USD | 2.45% |
| 2004 Q4 | 9.63 Billion USD | 5.86% |
| 2004 Q3 | 9.09 Billion USD | 3.69% |
| 2004 Q2 | 8.77 Billion USD | 2.49% |
| 2004 Q1 | 8.56 Billion USD | 44.72% |
| 2004 FY | 9.63 Billion USD | 62.82% |
| 2003 Q4 | 5.91 Billion USD | 9.02% |
| 2003 Q3 | 5.42 Billion USD | 3.68% |
| 2003 Q2 | 5.23 Billion USD | 7.41% |
| 2003 Q1 | 4.87 Billion USD | 5.31% |
| 2003 FY | 5.91 Billion USD | 27.86% |
| 2002 Q3 | 3.89 Billion USD | 2.82% |
| 2002 Q2 | 3.78 Billion USD | 7.76% |
| 2002 Q1 | 3.51 Billion USD | 1.57% |
| 2002 FY | 4.62 Billion USD | 33.72% |
| 2002 Q4 | 4.62 Billion USD | 18.82% |
| 2001 Q4 | 3.46 Billion USD | 1.9% |
| 2001 FY | 3.46 Billion USD | 21.17% |
| 2001 Q1 | 2.79 Billion USD | -2.04% |
| 2001 Q2 | 2.84 Billion USD | 1.69% |
| 2001 Q3 | 3.39 Billion USD | 19.36% |
| 2000 Q1 | 1.74 Billion USD | 1.65% |
| 2000 FY | 2.85 Billion USD | 66.6% |
| 2000 Q2 | 2.38 Billion USD | 36.62% |
| 2000 Q4 | 2.85 Billion USD | 20.43% |
| 2000 Q3 | 2.37 Billion USD | -0.39% |
| 1999 Q2 | 1.43 Billion USD | 1.24% |
| 1999 Q3 | 1.74 Billion USD | 21.65% |
| 1999 Q4 | 1.71 Billion USD | -1.89% |
| 1999 FY | 1.71 Billion USD | 19.36% |
| 1999 Q1 | 1.41 Billion USD | -1.22% |
| 1998 Q3 | 1.42 Billion USD | 10.69% |
| 1998 Q2 | 1.28 Billion USD | 9.86% |
| 1998 Q1 | 1.16 Billion USD | -1.59% |
| 1998 Q4 | 1.43 Billion USD | 0.98% |
| 1998 FY | 1.43 Billion USD | 20.83% |
| 1997 Q4 | 1.18 Billion USD | 0.0% |
| 1997 FY | 1.18 Billion USD | -4.27% |
| 1996 Q4 | 1.24 Billion USD | 0.0% |
| 1996 FY | 1.24 Billion USD | 42.48% |
| 1995 FY | 871.3 Million USD | 28.89% |
| 1995 Q4 | 871.3 Million USD | 0.0% |
| 1994 FY | 676 Million USD | 20.09% |
| 1994 Q4 | 676 Million USD | 0.0% |
| 1993 FY | 562.9 Million USD | 26.49% |
| 1993 Q4 | 562.9 Million USD | 0.0% |
| 1992 Q4 | 445 Million USD | 0.0% |
| 1992 FY | 445 Million USD | 18.13% |
| 1991 FY | 376.7 Million USD | 9.57% |
| 1991 Q4 | 376.7 Million USD | 0.0% |
| 1990 Q4 | 343.8 Million USD | 0.0% |
| 1990 FY | 343.8 Million USD | 19.92% |
| 1989 FY | 286.7 Million USD | 15.56% |
| 1989 Q4 | 286.7 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 3.47 Billion USD | -1152.07% |
| Bausch Health Companies Inc. | 27.35 Billion USD | -58.973% |
| Catalent, Inc. | 9.75 Billion USD | -345.801% |
| Emergent BioSolutions Inc. | 1.83 Billion USD | -2269.557% |
| Elanco Animal Health Incorporated | 14.36 Billion USD | -202.736% |
| Perrigo Company plc | 10.8 Billion USD | -302.244% |
| Zoetis Inc. | 14.28 Billion USD | -204.347% |